查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1765141

全球骨科生物製品市场

Orthobiologics
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计到 2030 年全球骨科生物製剂市场规模将达 90 亿美元

全球骨科生物製剂市场规模预计在2024年为71亿美元，预计到2030年将达到90亿美元，2024年至2030年的复合年增长率为4.2%。报告中分析的细分市场之一—关节内粘稠补充疗法，预计其复合年增长率为5.1%，到分析期结束时规模将达到41亿美元。合成骨科生物製剂细分市场在分析期间的复合年增长率预计为3.4%。

美国市场规模估计为 19 亿美元，中国市场预期复合年增长率为 3.8%

美国骨科生物製剂市场规模预计2024年达到19亿美元。作为世界第二大经济体，中国市场规模预计到2030年将达到14亿美元，在2024-2030年的分析期间内，复合年增长率为3.8%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为3.9%和3.5%。在欧洲，预计德国市场的复合年增长率为3.1%。

全球骨科生物学市场—主要趋势与驱动因素摘要

什么是骨科生物学？为什么它在整形外科医学中如此重要？

骨科生物製剂是生物衍生物质，用于促进整形外科手术中骨骼、肌肉、肌腱和韧带的癒合。这些物质包括富血小板血浆 (PRP)、骨移植、干细胞和透明质酸，旨在透过减少发炎、促进组织再生和加速康復来改善人体的自然癒合过程。骨科生物製剂广泛用于治疗运动伤害、退化性关节疾病和脊椎疾病，为患者提供创伤性较小的手术替代方案，或在某些情况下，作为辅助性治疗改善手术效果。透过利用人体的自​​然再生能力，骨科生物製剂是肌肉骨骼治疗的一项有希望的进步，可加快癒合速度并减少与传统治疗相关的併发症。越来越多的患者寻求非手术治疗方法，以及生物製剂在整形外科生物製药的广泛应用。

技术进步如何影响骨科生物学产业？

技术创新正在推动骨科生物製品市场的发展，尤其是在再生医学和组织工程领域。干细胞研究的进展拓宽了再生医学的可能性，基于干细胞的治疗已显示出修復整形外科患者软骨、骨骼和软组织的潜力。改良的富血小板血浆 (PRP) 疗法，即将浓缩的血小板注射到受损组织以促进癒合，也提高了各种肌肉骨骼损伤非手术治疗的有效性。此外，模拟天然骨特性的合成骨移植材料的开发，为骨科医生在脊椎融合手术和创伤病例中提供了更多骨再生的选择。此外，骨科生物製品输送系统的创新，例如支架和水凝胶的使用，提高了这些治疗的精确度和有效性。这些技术进步拓宽了骨科生物製品的应用范围，使其能够应用于从关节修復到脊椎畸形等更广泛的疾病。

骨科生物学最常用于哪些领域？

骨科生物材料主要用于整形外科、运动医学和创伤护理，在脊椎融合手术、关节修復和软组织再生方面的应用日益广泛。在运动医学中，PRP 和干细胞疗法被广泛用于治疗肌腱炎、韧带断裂和软骨损伤等损伤，帮助运动员更快康復并避免手术。在整形外科中，骨科生物材料经常用于脊椎融合手术等手术，这些手术需要骨移植或人工骨骼替代物来刺激骨骼生长和稳定脊椎。关节重组，特别是膝关节和肩关节的重建，是骨科生物材料经常用于促进组织修復和缩短恢復时间的另一个领域。此外，骨科生物材料也用于治疗骨关节炎等退化性关节疾病，帮助缓解疼痛和恢復关节功能。它们也被用于创伤护理，特别是对于需要增强骨癒合的复杂骨折。

什么因素推动了骨科生物学市场的成长？

骨科生物製品市场的成长受到多种因素的推动，包括肌肉骨骼疾病盛行率的上升、对微创手术的需求不断增长以及再生医学的进步。其中一个主要驱动因素是全球人口老化，这导致骨关节炎和骨质疏鬆症等整形外科疾病的盛行率居高不下，而骨科生物製品治疗可有效治疗这两种疾病。对微创和非手术治疗方法的需求不断增长也是一个关键驱动因素。干细胞疗法、富血小板血浆 (PRP) 和移植骨替代物等技术进步进一步拓宽了骨科生物製品可治疗的疾病范围，使其更有效且更容易获得。此外，职业运动员和寻求尖端治疗的活跃人士越来越多地将骨科生物製品应用于运动医学，这也促进了市场的成长。最后，人们对生物製药在整形外科医学中益处的认识不断提高，以及该领域正在进行的研究和开发，正在推动这些治疗方法在临床和外科环境中的广泛使用。

部分

产品（关节内粘稠补充疗法、合成骨科生物製剂、DBM、BMP、其他产品）；应用（骨关节炎和退化性关节炎、骨折修復、脊椎融合、软组织损伤、其他应用）

受访公司范例

  • Arthrex, Inc.
  • Bioventus LLC
  • DePuy Synthes
  • Globus Medical, Inc.
  • K2M Group Holdings, Inc.
  • Kuros Biosciences AG
  • Medtronic PLC
  • NuVasive, Inc.
  • Orthofix International NV
  • RTI Surgical, Inc.
  • SeaSpine Holdings Corporation
  • Stryker Corporation
  • XTANT Medical Holdings, Inc.
  • Zimmer Biomet Holdings, Inc.

人工智慧集成

我们正在利用可操作的专家内容和人工智慧工具来改变市场和竞争情报。

Global 特定产业SLM 的典型规范，而是建立了一个从全球专家收集的内容库，其中包括视讯录影、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地、进出口状况（成品和原始OEM）预测其竞争态势的变化。这种复杂且多面向的市场动态预计将以多种方式影响竞争对手，包括销货成本成本 (COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他地区

第四章 比赛

简介目录
Product Code: MCP13776

Global Orthobiologics Market to Reach US$9.0 Billion by 2030

The global market for Orthobiologics estimated at US$7.1 Billion in the year 2024, is expected to reach US$9.0 Billion by 2030, growing at a CAGR of 4.2% over the analysis period 2024-2030. Viscosupplementation, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$4.1 Billion by the end of the analysis period. Growth in the Synthetic Orthobiologics segment is estimated at 3.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.9 Billion While China is Forecast to Grow at 3.8% CAGR

The Orthobiologics market in the U.S. is estimated at US$1.9 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.4 Billion by the year 2030 trailing a CAGR of 3.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.9% and 3.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.1% CAGR.

Global Orthobiologics Market - Key Trends & Drivers Summarized

What Are Orthobiologics, and Why Are They Critical in Orthopedic Medicine?

Orthobiologics are biologically derived substances used to enhance the healing of bones, muscles, tendons, and ligaments in orthopedic procedures. These substances, which include platelet-rich plasma (PRP), bone grafts, stem cells, and hyaluronic acid, are designed to improve the body’s natural healing processes by reducing inflammation, promoting tissue regeneration, and accelerating recovery. Orthobiologics are widely used in treatments for sports injuries, degenerative joint diseases, and spinal conditions, offering patients a minimally invasive option to surgery or, in some cases, improving surgical outcomes when used as an adjunct therapy. By leveraging the body’s natural regenerative capacity, orthobiologics represent a promising advancement in musculoskeletal care, providing faster healing and reducing complications associated with traditional treatments. Their growing adoption is being driven by increased patient demand for non-surgical treatment options and the rise of biologics in orthopedic surgery.

How Are Technological Advancements Shaping the Orthobiologics Industry?

Technological innovations are propelling the orthobiologics market forward, particularly in the areas of regenerative medicine and tissue engineering. Advances in stem cell research have expanded the possibilities for regenerative treatments, with stem cell-based therapies showing promise in repairing cartilage, bone, and soft tissues in orthopedic patients. The refinement of platelet-rich plasma (PRP) therapies, where concentrated platelets are injected into damaged tissue to promote healing, has also increased the effectiveness of non-surgical treatments for a variety of musculoskeletal injuries. Furthermore, developments in synthetic bone graft substitutes, which mimic the properties of natural bone, are offering orthopedic surgeons more options for bone regeneration in spinal fusion and trauma cases. Additionally, innovations in the delivery systems for orthobiologics, such as the use of scaffolds or hydrogels, are improving the precision and efficacy of these therapies. These technological advancements are enhancing the scope of orthobiologics, making them more versatile and applicable to a wider range of conditions, from joint repair to spinal deformities.

Where Are Orthobiologics Being Used Most Extensively?

Orthobiologics are primarily used in orthopedic surgeries, sports medicine, and trauma care, with increasing applications in spinal fusion, joint repair, and soft tissue regeneration. In sports medicine, PRP and stem cell therapies are widely used to treat injuries such as tendonitis, ligament tears, and cartilage damage, helping athletes recover faster and avoid surgery. In orthopedic surgery, orthobiologics are frequently used in procedures like spinal fusion, where bone grafts or bone substitutes are needed to promote bone growth and stabilize the spine. Joint reconstruction, particularly in the knee and shoulder, is another area where orthobiologics are commonly employed to enhance tissue repair and reduce recovery times. Moreover, orthobiologics are gaining traction in treating degenerative joint diseases such as osteoarthritis, where they help alleviate pain and restore joint function. Their use in trauma care is also expanding, particularly for complex fractures that require enhanced bone healing.

What Is Driving the Growth of the Orthobiologics Market?

The growth in the orthobiologics market is driven by several factors, including the rising prevalence of musculoskeletal disorders, an increasing demand for minimally invasive procedures, and advancements in regenerative medicine. One of the primary drivers is the aging global population, which is leading to a higher incidence of orthopedic conditions such as osteoarthritis and osteoporosis, both of which benefit from orthobiologic treatments. The growing demand for minimally invasive and non-surgical treatment options is another significant driver, as patients increasingly seek alternatives to traditional surgery for faster recovery and fewer complications. Technological advancements in stem cell therapies, platelet-rich plasma (PRP), and bone graft substitutes are further expanding the range of conditions that can be treated with orthobiologics, making them more effective and accessible. Additionally, the increasing adoption of orthobiologics in sports medicine, driven by professional athletes and active individuals looking for cutting-edge treatments, is contributing to market growth. Lastly, the rising awareness of the benefits of biologics in orthopedic care, coupled with ongoing research and development in the field, is driving the broader use of these therapies in both clinical and surgical settings.

SCOPE OF STUDY:

The report analyzes the Orthobiologics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Viscosupplementation, Synthetic Orthobiologics, DBM, BMP, Other Products); Application (Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 44 Featured) -

  • Arthrex, Inc.
  • Bioventus LLC
  • DePuy Synthes
  • Globus Medical, Inc.
  • K2M Group Holdings, Inc.
  • Kuros Biosciences AG
  • Medtronic PLC
  • NuVasive, Inc.
  • Orthofix International NV
  • RTI Surgical, Inc.
  • SeaSpine Holdings Corporation
  • Stryker Corporation
  • XTANT Medical Holdings, Inc.
  • Zimmer Biomet Holdings, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Global Economic Update
    • Orthobiologics - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Musculoskeletal Disorders Spurs Growth in the Orthobiologics Market
    • Growing Demand for Minimally Invasive Surgical Techniques Strengthens Business Case for Orthobiologics
    • Increasing Focus on Regenerative Medicine Drives Adoption of Orthobiologics in Joint Repair and Replacement
    • Advancements in Stem Cell and Growth Factor Therapies Propel Innovation in Orthobiologics
    • Surge in Aging Population and Increasing Incidence of Osteoarthritis Expands Addressable Market for Orthobiologics
    • Growing Focus on Biocompatibility and Bioabsorbable Materials Fuels Innovation in Orthobiologic Products
    • Rising Use of Orthobiologics in Sports Medicine Fuels Growth in Cartilage Repair and Tissue Regeneration
    • Growing Application of Orthobiologics in Fracture Healing Expands Opportunities in Trauma Care
    • Increasing Focus on Personalized Orthopedic Treatments Drives Demand for Orthobiologics in Customized Therapies
    • Expansion of Orthobiologics in Non-Surgical Treatments for Chronic Pain and Joint Degeneration Propels Market Growth
    • Advances in 3D Printing and Biologics-Based Implants Strengthen Market for Orthobiologics in Complex Surgeries
    • Increasing Use of Platelet-Rich Plasma (PRP) in Orthopedic Therapies Expands the Orthobiologics Market
    • Rising Demand for Orthobiologics in Spinal Fusion Procedures Boosts Market Opportunities
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Orthobiologics Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Orthobiologics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Orthobiologics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Orthobiologics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Viscosupplementation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Viscosupplementation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Viscosupplementation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Synthetic Orthobiologics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Synthetic Orthobiologics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Synthetic Orthobiologics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for DBM by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for DBM by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for DBM by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for BMP by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for BMP by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for BMP by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Osteoarthritis & Degenerative Arthritis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Osteoarthritis & Degenerative Arthritis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Osteoarthritis & Degenerative Arthritis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Fracture Recovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Fracture Recovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Fracture Recovery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Spinal Fusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Spinal Fusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Spinal Fusion by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Soft Tissue Injuries by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Soft Tissue Injuries by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Soft Tissue Injuries by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Orthobiologics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Orthobiologics by Product - Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Orthobiologics by Product - Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Orthobiologics by Product - Percentage Breakdown of Value Sales for Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Orthobiologics by Application - Percentage Breakdown of Value Sales for Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Orthobiologics by Product - Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Orthobiologics by Product - Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Orthobiologics by Product - Percentage Breakdown of Value Sales for Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products for the Years 2015, 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Orthobiologics by Application - Percentage Breakdown of Value Sales for Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications for the Years 2015, 2025 & 2030
  • JAPAN
    • Orthobiologics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Orthobiologics by Product - Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Orthobiologics by Product - Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Japan 15-Year Perspective for Orthobiologics by Product - Percentage Breakdown of Value Sales for Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products for the Years 2015, 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for Orthobiologics by Application - Percentage Breakdown of Value Sales for Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications for the Years 2015, 2025 & 2030
  • CHINA
    • Orthobiologics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 53: China Recent Past, Current & Future Analysis for Orthobiologics by Product - Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Orthobiologics by Product - Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: China 15-Year Perspective for Orthobiologics by Product - Percentage Breakdown of Value Sales for Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products for the Years 2015, 2025 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: China 15-Year Perspective for Orthobiologics by Application - Percentage Breakdown of Value Sales for Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications for the Years 2015, 2025 & 2030
  • EUROPE
    • Orthobiologics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Orthobiologics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Orthobiologics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Europe 15-Year Perspective for Orthobiologics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Orthobiologics by Product - Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Orthobiologics by Product - Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Europe 15-Year Perspective for Orthobiologics by Product - Percentage Breakdown of Value Sales for Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products for the Years 2015, 2025 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Europe 15-Year Perspective for Orthobiologics by Application - Percentage Breakdown of Value Sales for Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications for the Years 2015, 2025 & 2030
  • FRANCE
    • Orthobiologics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 68: France Recent Past, Current & Future Analysis for Orthobiologics by Product - Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: France Historic Review for Orthobiologics by Product - Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: France 15-Year Perspective for Orthobiologics by Product - Percentage Breakdown of Value Sales for Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products for the Years 2015, 2025 & 2030
    • TABLE 71: France Recent Past, Current & Future Analysis for Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: France Historic Review for Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: France 15-Year Perspective for Orthobiologics by Application - Percentage Breakdown of Value Sales for Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications for the Years 2015, 2025 & 2030
  • GERMANY
    • Orthobiologics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Orthobiologics by Product - Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for Orthobiologics by Product - Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Germany 15-Year Perspective for Orthobiologics by Product - Percentage Breakdown of Value Sales for Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products for the Years 2015, 2025 & 2030
    • TABLE 77: Germany Recent Past, Current & Future Analysis for Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Germany Historic Review for Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Germany 15-Year Perspective for Orthobiologics by Application - Percentage Breakdown of Value Sales for Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Orthobiologics by Product - Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for Orthobiologics by Product - Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Italy 15-Year Perspective for Orthobiologics by Product - Percentage Breakdown of Value Sales for Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products for the Years 2015, 2025 & 2030
    • TABLE 83: Italy Recent Past, Current & Future Analysis for Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Italy Historic Review for Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Italy 15-Year Perspective for Orthobiologics by Application - Percentage Breakdown of Value Sales for Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Orthobiologics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 86: UK Recent Past, Current & Future Analysis for Orthobiologics by Product - Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for Orthobiologics by Product - Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: UK 15-Year Perspective for Orthobiologics by Product - Percentage Breakdown of Value Sales for Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products for the Years 2015, 2025 & 2030
    • TABLE 89: UK Recent Past, Current & Future Analysis for Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: UK Historic Review for Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: UK 15-Year Perspective for Orthobiologics by Application - Percentage Breakdown of Value Sales for Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Orthobiologics by Product - Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Orthobiologics by Product - Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for Orthobiologics by Product - Percentage Breakdown of Value Sales for Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products for the Years 2015, 2025 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Orthobiologics by Application - Percentage Breakdown of Value Sales for Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Orthobiologics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Orthobiologics by Product - Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Orthobiologics by Product - Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Orthobiologics by Product - Percentage Breakdown of Value Sales for Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products for the Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Orthobiologics by Application - Percentage Breakdown of Value Sales for Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 104: Rest of World Recent Past, Current & Future Analysis for Orthobiologics by Product - Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of World Historic Review for Orthobiologics by Product - Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Rest of World 15-Year Perspective for Orthobiologics by Product - Percentage Breakdown of Value Sales for Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products for the Years 2015, 2025 & 2030
    • TABLE 107: Rest of World Recent Past, Current & Future Analysis for Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Rest of World Historic Review for Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Rest of World 15-Year Perspective for Orthobiologics by Application - Percentage Breakdown of Value Sales for Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION